Clinical trial
A Randomised, Double Blind, Placebo Controlled, Parallel Group, Dose Ranging Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes
NCT02053272 is registered in ClinicalTrials.gov with Jazz Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Double Blind, Placebo Controlled, Parallel Group, Dose Ranging Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes
- Lead sponsor
- Jazz Pharmaceuticals
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- February 29, 2016
- Enrollment
- 207 (actual)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.